Evaluation of Rivastigmine Therapy with Tc99m HMPAO Brain Perfusion SPECT and MMSE Scores in Alzheimer's Disease

Basit Öğe Kaydı
dc.contributor.authorCerci, S. S.
dc.contributor.authorKaya, H.
dc.contributor.authorYildiz, M.
dc.contributor.authorTamam, Y.
dc.contributor.authorArslan, S.
dc.date.accessioned2024-04-24T17:47:38Z
dc.date.available2024-04-24T17:47:38Z
dc.date.issued2005
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS185en_US
dc.identifier.issn1619-7070
dc.identifier.startpageS185en_US
dc.identifier.urihttps://hdl.handle.net/11468/22654
dc.identifier.volume32en_US
dc.identifier.wosWOS:000208745101191
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofEuropean Journal of Nuclear Medicine and Molecular Imaging
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleEvaluation of Rivastigmine Therapy with Tc99m HMPAO Brain Perfusion SPECT and MMSE Scores in Alzheimer's Diseaseen_US
dc.titleEvaluation of Rivastigmine Therapy with Tc99m HMPAO Brain Perfusion SPECT and MMSE Scores in Alzheimer's Disease
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu